Cymbalta and Social problem - a phase IV clinical study of FDA data

Summary:

Social problem is reported as a side effect among people who take Cymbalta (duloxetine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Benlysta, and have Systemic lupus erythematosus.

The phase IV clinical study analyzes which people have Social problem when taking Cymbalta. It is created by eHealthMe based on reports of 145,249 people who have side effects when taking Cymbalta from the FDA, and is updated regularly.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,976 Cymbalta users. Check the latest studies of Cymbalta.

What is Social problem?

Social problem is found to be associated with 373 drugs and 374 conditions by eHealthMe. Check the latest studies of Social problem.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

145,249 people reported to have side effects when taking Cymbalta.
Among them, 65 people (0.04%) have Social problem.

Among these 65 people:

How long have people been on Cymbalta when they have Social problem? *

What is the gender of people who have Social problem when taking Cymbalta? *

female: 74.14 %
male: 25.86 %

What is the age of people who have Social problem when taking Cymbalta? *

What are other drugs people take besides Cymbalta? *

What are other side effects people have besides Social problem? *

Pain: 25 people, 38.46%
High Blood Pressure: 22 people, 33.85%
Inflammation: 20 people, 30.77%
Drowsiness: 19 people, 29.23%
Drug Ineffective: 19 people, 29.23%
Joint Pain: 17 people, 26.15%
Gait Disturbance: 16 people, 24.62%
Nasopharyngitis (inflammation of the nasopharynx): 16 people, 24.62%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 15 people, 23.08%
Weight Increased: 15 people, 23.08%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 20 people, 30.77%
Kidney Stones: 14 people, 21.54%
Pain: 14 people, 21.54%
Ear Discomfort: 13 people, 20.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 12 people, 18.46%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 9.23%
Pituitary Tumor Benign: 6 people, 9.23%
Psychotic Disorder: 4 people, 6.15%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 6.15%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 4.62%

* Approximation only. Some reports may have incomplete information.

Do you take Cymbalta and have Social problem?

- Check whether Social problem is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cymbalta:

Cymbalta (154,976 reports)

Social problem treatments and more:

Social problem (4,682 reports)

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Social problem:

Social problem (373 drugs)

Browse all the conditions that are associated with Social problem:

Social problem (374 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on duloxetine hydrochloride (the active ingredients of Cymbalta) and Cymbalta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.